FDA deputy commissioner Scott Gottlieb MD, former FDA Commissioner Jane Henney MD, former FDA Chief Counsel Dan Troy & Assoc US Attorney Jim Sheehan to keynote the 2006 FDA Regulatory & Compliance Symposium
— Managing Risks – From Pipeline to Patient
— Aug 24-26 2006 — Symposium Hotels: Charles Hotel, Cambridge MA
— Classes Held in Harvard University’s Annenberg Hall & Sanders Theatre,
February 7, 2006 — /MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM)/ — CAMBRIDGE, Mass. — The 2nd FDA Regulatory & Compliance Symposium, http://sacserv.com/tracking.jsp?linkid=30004&subid=3838834&campid=146393&type=0, Aug 23-25 2006, in Cambridge MA announced today its keynote faculty to date. The FDA Symposium is sponsored by the Harvard Health Policy Review, Health Affairs and FDAnews.
— Scott Gottlieb MD, Deputy Commissioner for Medical & Scientific Affairs, Office of the Commissioner, FDA, Washington DC
— Jane E. Henney MD, Sr VP & Provost for Health Affairs, Univ of Cincinnati Medical Ctr, & Former FDA Commissioner, Cincinnati OH
— James Sheehan Esq, Assoc US Attorney, US Attorney’s Office for East District of Penn, Philadelphia PA
— Daniel E. Troy Esq, Partner, Sidley Austin Brown & Wood, Former Chief Counsel, Office of the General Counsel, FDA, Washington DC
CALL FOR SPEAKERS & PRESENTATION PROPOSALS:
Individuals interested in making presentation proposals for the 2nd FDA Regulatory & Compliance Symposium, Aug 23-25 2006, in Cambridge MA, may submit a proposal by going to:
To assure consideration, presentation proposals should be submitted by Fri Feb 10 2006.
Rarely have there been so many major changes and uncertainties with such far-reaching consequences to drug development, manufacturing, monitoring and marketing. And rarely has there been a greater need to bring together reps and advisors from government and the world’s leading drug makers to share strategies for regaining consumer confidence in today’s medicines.
The FDA Regulatory & Compliance Symposium – a unique 3-day, high-level forum in one of the world’s most famous academic settings – will help drug makers prepare for the full impact of all changes flowing from the FDA and Congress, while clarifying many of the uncertainties. The Symposium will also provide practical, state-of-the-art solutions to challenges of eliminating or reducing risks throughout the product life-cycle – from the drug pipeline to manufacturing to patient delivery.
The Symposium is on the Harvard University campus. Classes are in Annenberg Hall of the Sanders Theatre Complex. Inspired by the great halls of Oxford and Cambridge Universities, this room is arguably the most impressive space at Harvard. Harvard University, the oldest institution of higher learning in the US was established in 1636. Today, Harvard has grown to become a great undergraduate and graduate research university.
EXHIBIT & SPONSORSHIP INFORMATION:
300 N Washington St Ste 200
Falls Church VA USA 22046
100 N 20th St 4th Fl
Philadelphia PA USA 19103
For further registration information, go to
call 800-684-4549, [email protected] or write:
FDA Symposium Office
7790 Barberry Ave
Yucca Valley CA USA 92284